U.S. Markets Closed Mixed Wednesday As Okta Led, Humana Lagged
U.S. stock indexes closed mixed Wednesday as the NASDAQ Composite Index gained 0.42%. Meanwhile, the S&P 500 Index 0.23%, and the Dow declined 1.11%.
Archived explainer. For the current picture see today's HUM page.
HUMANA INC (HUM) is down -12.98% in the latest session. Our newswire has captured 4 stories on HUM across 4 sources in the last 36 hours, with AI sentiment reading mixed (avg 43/100).
Humana Inc (HUM) shares fell 12.98% to $385.78 amid a broad selloff in the health insurance sector. The decline was driven by a proposed Medicare Advantage audit framework that would allow regulators to claw back overbilling going back to 2018.
The drop occurred as UnitedHealth Group and Elevance Health also experienced significant losses, with peers dropping nearly 9% and just over 6% respectively. The proposed crackdown on overbilling by private insurance plans triggered the sector-wide retreat. While Humana lagged the broader market, the specific catalyst was the regulatory proposal targeting historical billing practices.
The stock’s 52-week range spans from $163.11 to $462.87, and the shares printed 63 fresh 52-week lows on November 18, 2026. Over the last eight sessions, the stock has moved down 8.8%, falling from $423.22 to the current price. Fundamentals show a market cap of $55.4B, a P/E ratio of 43.1, and a net margin of 0.8%. Revenue growth stands at 22.0% on a trailing twelve-month basis, with a beta of 0.64 and a dividend yield of 0.77%.
Insider activity includes two sales totaling $2.6M in the last 90 days, with the most recent filing dated November 12, 2026. Director Frederick Wayne A.I. sold shares on November 10, 2026, and General Counsel Ventura Joseph C sold on November 9, 2026. Congressional disclosures show Donald J. Trump sold between $15,001 and $50,000 on July 8, 2026. Retail chatter on social platforms reflects the sharp decline, with users noting the impact of the Medicare proposal on insurers.
Investors are monitoring the development of the proposed Medicare Advantage audit framework and its potential impact on future revenue recognition. The next scheduled dividend is set for an ex-date of October 30, 2026, with a payout of $0.885 per share.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
U.S. stock indexes closed mixed Wednesday as the NASDAQ Composite Index gained 0.42%. Meanwhile, the S&P 500 Index 0.23%, and the Dow declined 1.11%.
Elevance Health shares fell just over 6% to $406.77 as UnitedHealth dropped nearly 9% and Humana fell more than 10% in a broad insurer selloff.
More on HUM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier HUM move explainers: 2026-11-19 · 2026-11-18 · 2026-11-17 · 2026-10-12 · 2026-10-09 · 2026-09-25